CAN-ASC is a Canada-wide consortium of researchers and clinician scientists. We collaborate with international networks from academia and industry to develop consensus-driven, standardized and validated operating procedures (SOPs) for human immunology research.
The Canucks for Kids Fund Childhood Diabetes Laboratories aim to improve the lives of children with diabetes by advancing knowledge of type 1 and type 2 diabetes, through innovative and multi-disciplinary basic and clinical diabetes research.
Researchers with the Michael Cuccione Childhood Cancer Research Program embrace one goal: to save children’s lives, while improving their health and quality of life through every phase of treatment and recovery.
A new study suggests that specialized immune cells that dampen inflammation and help repair the gut could be used as a potential therapy for children dealing with the painful symptoms of inflammatory bowel disease.
Scientists have developed a molecular “clock” that could reshape how pediatricians measure and monitor childhood growth and potentially allow for an earlier diagnosis of life-altering development disorders. The research, published this week in PNAS, describes how the addition of chemical tags to DNA over time can potentially be used to screen for developmental differences and health problems in children.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.